These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1754013)

  • 1. Pharmacokinetic correlates of fetal drug exposure.
    DeVane CL
    NIDA Res Monogr; 1991; 114():18-36. PubMed ID: 1754013
    [No Abstract]   [Full Text] [Related]  

  • 2. Animal models for study of fetal drug exposure.
    Rudolph AM
    NIDA Res Monogr; 1985; 60():5-16. PubMed ID: 3932866
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of maternal-fetal transport of drugs of abuse: a critical review.
    Melethil S
    NIDA Res Monogr; 1995; 154():132-51. PubMed ID: 8606741
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drugs as a factor threatening the fetus].
    Zdziennicki A
    Wiad Lek; 1990 Nov 1-15; 43(21-22):1068-70. PubMed ID: 2082584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a physiologically based pharmacokinetic model for bisphenol A in pregnant mice.
    Kawamoto Y; Matsuyama W; Wada M; Hishikawa J; Chan MP; Nakayama A; Morisawa S
    Toxicol Appl Pharmacol; 2007 Oct; 224(2):182-91. PubMed ID: 17698157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological principles in pregnancy].
    Villanueva LA; Valenzuela F
    Gac Med Mex; 1998; 134(5):575-82. PubMed ID: 9842139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of pharmacokinetics in realizing the embryotoxic action of drugs].
    Smol'nikova NM; Boĭko SS; Liubimov BI
    Farmakol Toksikol; 1986; 49(2):106-11. PubMed ID: 3519275
    [No Abstract]   [Full Text] [Related]  

  • 8. Construction of a physiologically based pharmacokinetic model for 2,4-dichlorophenoxyacetic acid dosimetry in the developing rabbit brain.
    Kim CS; Binienda Z; Sandberg JA
    Toxicol Appl Pharmacol; 1996 Feb; 136(2):250-9. PubMed ID: 8619233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A physiologically based pharmacokinetic computer model for human pregnancy.
    Luecke RH; Wosilait WD; Pearce BA; Young JF
    Teratology; 1994 Feb; 49(2):90-103. PubMed ID: 8016750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic considerations for the design and screening of potential medications.
    DeVane CL
    NIDA Res Monogr; 1995; 149():116-29. PubMed ID: 8775838
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of pharmacokinetic variables in reproductive and developmental toxicity.
    Neubert D
    Xenobiotica; 1988 Jan; 18 Suppl 1():45-58. PubMed ID: 3278490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of transplacental clearances and fetal clearance to drug disposition in the ovine maternal-fetal unit.
    Szeto HH; Umans JG; Rubinow SI
    Drug Metab Dispos; 1982; 10(4):382-6. PubMed ID: 6126338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of salicylate on maternal and fetal phenytoin pharmacokinetics in rats.
    Cleveland PA; Ueda CT
    Drug Metab Dispos; 1984; 12(3):285-90. PubMed ID: 6145554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ivermectin after maternal or fetal intravenous administration in sheep.
    Pérez R; Palma C; Núñez MJ; Cox J
    J Vet Pharmacol Ther; 2008 Oct; 31(5):406-14. PubMed ID: 19000259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically based pharmacokinetics of methoxyacetic acid: dose-effect considerations in C57BL/6 mice.
    O'Flaherty EJ; Nau H; McCandless D; Beliles RP; Schreiner CM; Scott WJ
    Teratology; 1995 Aug; 52(2):78-89. PubMed ID: 8588185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of drugs and metabolites in the maternal-placental-fetal unit: general principles.
    Wang LH; Rudolph AM; Benet LZ
    NIDA Res Monogr; 1985; 60():25-38. PubMed ID: 3932864
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological treatment of the fetus. Clinical pharmacokinetic considerations.
    Ward RM
    Clin Pharmacokinet; 1995 May; 28(5):343-50. PubMed ID: 7614774
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of fetal and neonatal exposure to drugs.
    Levy G
    Obstet Gynecol; 1981 Nov; 58(5 Suppl):9S-16S. PubMed ID: 7031546
    [No Abstract]   [Full Text] [Related]  

  • 19. Materno-fetal pharmacokinetics and fetal distribution of valproic acid in a pregnant rhesus monkey.
    Dickinson RG; Lawyer CH; Kaufman SN; Lynn RK; Gerber N; Novy MJ; Cook MJ
    Pediatr Pharmacol (New York); 1980; 1(1):71-83. PubMed ID: 6810290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose.
    DeVane CL; Simpkins JW
    Drug Metab Dispos; 1985; 13(4):438-42. PubMed ID: 2863107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.